Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rational polypharmacy

A Richens1

  • 1Department of Pharmacology and Therapeutics, University of Wales College of Medicine, Cardiff, UK.

Seizure
|September 1, 1995
PubMed
Summary
This summary is machine-generated.

Monotherapy is the standard for epilepsy treatment, but many patients require combination therapy. Further research is needed to compare the effectiveness and safety of monotherapy versus combination antiepileptic drug treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of generic substitution of anticonvulsants on the treatment of epilepsy.

CNS drugs·2013
Same author

Inhibition of phenytoin metabolism by sulthiame in epileptic patients.

British journal of clinical pharmacology·2012
Same author

Effect of diazepam on oculomotor balance.

British journal of clinical pharmacology·2012
Same author

Rate of elimination of tracer doses of phenytoin at different steady-state serum phenytoin concentrations in epileptic patients.

British journal of clinical pharmacology·2012
Same author

The influence of elevated plasma hydrocortisone concentrations on antipyrine metabolism in man.

British journal of clinical pharmacology·2012
Same author

α-adrenoceptor blocking drugs, pressor responses to noradrenaline, and the ankle jerk in man.

British journal of clinical pharmacology·2012
Same journal

Effect of chronic migraine treatment on functional seizure frequency: An exploratory study.

Seizure·2026
Same journal

Development of a standard for epilepsy semiology and semiological description dataset: a modified Delphi study.

Seizure·2026
Same journal

UNC13A-related neurodevelopmental disorders in children: epilepsy phenotypes and antiseizure medication response.

Seizure·2026
Same journal

Switching from oxcarbazepine to eslicarbazepine in patients with focal epilepsy: A systematic review and single-arm meta-analysis.

Seizure·2026
Same journal

Efficacy, tolerability, and EEG lateralization-based predictors of neuropsychiatric adverse events in pediatric SeLECTS treated with perampanel monotherapy.

Seizure·2026
Same journal

Cross-cultural validation of the International Classification of Cognitive Disorders in Epilepsy (IC-CoDE) in Chinese-speaking people with epilepsy.

Seizure·2026
See all related articles

Area of Science:

  • Pharmacology
  • Neurology
  • Clinical Pharmacy

Background:

  • Plasma antiepileptic drug concentration assays reveal pharmacokinetic interactions.
  • Epileptologists advocated for single drug therapy (monotherapy) for epilepsy treatment since the 1970s.
  • Monotherapy is the current standard for initiating epilepsy treatment.

Purpose of the Study:

  • To review the efficacy of monotherapy versus combination therapy in epilepsy treatment.
  • To highlight the need for randomized controlled trials comparing monotherapy and combination therapy.
  • To explore potential synergistic effects of combining drugs with different mechanisms of action.

Main Methods:

  • Review of existing literature on antiepileptic drug (AED) therapy.
  • Analysis of pharmacokinetic interactions and treatment outcomes.

Related Experiment Videos

  • Discussion of evidence regarding add-on therapy with newer AEDs like vigabatrin.

    • Main Results:

    • Approximately 75% of patients achieve remission with monotherapy.
    • Add-on therapy shows limited response rates, though some newer drugs offer significant seizure reduction.
    • Randomized placebo-controlled studies comparing monotherapy and combination therapy are lacking.

    Conclusions:

    • While monotherapy is effective for many, a significant portion of patients require combination therapy.
    • There is a critical need for rigorous studies to compare monotherapy and combination therapy.
    • Combining drugs with complementary mechanisms (e.g., excitation blockade and inhibition enhancement) may offer improved outcomes.